403 related articles for article (PubMed ID: 4216253)
1. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
[No Abstract] [Full Text] [Related]
2. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
[No Abstract] [Full Text] [Related]
3. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
[No Abstract] [Full Text] [Related]
4. Technological aspect of the production of live dysentery vaccines for oral administration.
Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K
Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499
[TBL] [Abstract][Full Text] [Related]
5. [Laboratory safety testing of live dysentery vaccine strains (author's transl)].
Lesniak SV; Levenbuk IS; Fedotova Y; Belaya M; Yu A; Sergeev VV; Jikidze EK; Kavtaradze KN; Elkina SL
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):87-97. PubMed ID: 4216254
[No Abstract] [Full Text] [Related]
6. Potential Shigella flexneri 2a and Shigella sonnei I live vaccinal strains. Characterization of immunogenicity in animal models.
Denchev V; Sumerska T; Marinova S; Vassilev T; Panova I; Linde K
Acta Microbiol Hung; 1990; 37(4):359-66. PubMed ID: 2099082
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
Oaks EV; Turbyfill KR
Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine.
Zhang HM; Li YP; Song LH; Yu XL; Liu NH; Kong XE; Li L; Zhai YL
Chin Med J (Engl); 1987 May; 100(5):425-8. PubMed ID: 3115716
[No Abstract] [Full Text] [Related]
10. Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.
Mel DM; Arsic BL; Radovanovic ML; Litvinjenko SA
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):109-14. PubMed ID: 4613128
[No Abstract] [Full Text] [Related]
11. [Humoral and cellular immunity in patients with acute dysentery].
Burkin AV; Kasimova NB; Galimzianova RM; Gor'kova AI; Shishkina SN
Ter Arkh; 1991; 63(11):22-5. PubMed ID: 1810054
[No Abstract] [Full Text] [Related]
12. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
[TBL] [Abstract][Full Text] [Related]
13. The cellular and humoral immune response after administration to the guinea pig of Shigella flexneri 2a T32--Istrati vaccinal strain by different routes.
Meitert T; Radu I; Ciudin L; Pencu E; Tonciu M
Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):267-76. PubMed ID: 395927
[No Abstract] [Full Text] [Related]
14. [Study of intestinal infections in experiments on monkeys].
Dzhikidze EK; Kavtaradze KN; Stasilevich ZK; Shaginian SA; Gvazava IS
Vestn Akad Med Nauk SSSR; 1977; (8):59-65. PubMed ID: 410189
[No Abstract] [Full Text] [Related]
15. Self-experiments with ingestion of various bacteria.
Rédey B
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):45-62. PubMed ID: 4216252
[No Abstract] [Full Text] [Related]
16. Oral immunization of monkeys with polyvalent dysentery vaccine.
Dhikidze EK; Kavtaradze KN; Krilova RI; Rauss K; Kétyi I; Vertényi A
Acta Microbiol Acad Sci Hung; 1977; 24(1):7-12. PubMed ID: 412396
[TBL] [Abstract][Full Text] [Related]
17. Oral immunization against dysentery.
Kétyi I; Rauss K; Vertényi A
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):81-5. PubMed ID: 4613142
[No Abstract] [Full Text] [Related]
18. Prophylaxis of bacillary dysentery by liver vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in IS County.
Oană C; Buzdugan T; Constantiniu S; Cismaru M; Alexandru D; Dunea C; Funiac A; Radu M; Grumăzescu C; Meitert T
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):331-5. PubMed ID: 6400307
[No Abstract] [Full Text] [Related]
19. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]